Inhibition of Nuclear Receptor Binding SET Domain 2/Multiple Myeloma SET Domain by LEM-06 Implication for Epigenetic Cancer Therapies

BACKGROUND: Multiple myeloma SET domain (MMSET)/nuclear receptor binding SET domain 2 (NSD2) is a lysine histone methyltransferase (HMTase) and bona fide oncoprotein found aberrantly expressed in several cancers, suggesting potential role for novel therapeutic strategies. In particular, MMSET/NSD2 i...

Descripción completa

Detalles Bibliográficos
Autor principal: di Luccio, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Cancer Prevention 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492355/
https://www.ncbi.nlm.nih.gov/pubmed/26151044
http://dx.doi.org/10.15430/JCP.2015.20.2.113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492355/
https://www.ncbi.nlm.nih.gov/pubmed/26151044
http://dx.doi.org/10.15430/JCP.2015.20.2.113

Ejemplares similares